Results 271 to 280 of about 912,080 (293)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2015
This letter provides a response by the Food and Drug Administration to the Special Report, in this issue of the Journal, regarding FDA premarket review of genetic tests.
E David, Litwack +2 more
openaire +2 more sources
This letter provides a response by the Food and Drug Administration to the Special Report, in this issue of the Journal, regarding FDA premarket review of genetic tests.
E David, Litwack +2 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2000
New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it
openaire +2 more sources
New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it
openaire +2 more sources
2009
This chapter addresses the potential use of genetic tests to predict performance and/or risk of exercise-related injury or illness. Various people may wish to conduct a sport-related genetic test on themselves, or on another person, for a variety of reasons.
Williams, Alun G., Wackerhage, Henning
openaire +3 more sources
This chapter addresses the potential use of genetic tests to predict performance and/or risk of exercise-related injury or illness. Various people may wish to conduct a sport-related genetic test on themselves, or on another person, for a variety of reasons.
Williams, Alun G., Wackerhage, Henning
openaire +3 more sources
New England Journal of Medicine, 1996
Genes have become the preferred way to explain all types of ill health and unwanted behavior. Some of the attributions seem fairly clear-cut, but many are being embraced uncritically and oversold.
R, Hubbard, R C, Lewontin
openaire +2 more sources
Genes have become the preferred way to explain all types of ill health and unwanted behavior. Some of the attributions seem fairly clear-cut, but many are being embraced uncritically and oversold.
R, Hubbard, R C, Lewontin
openaire +2 more sources
Preimplantation genetic testing
BMJ, 2012#### Summary points Preimplantation genetic (PG) testing is the practice of obtaining a cellular biopsy sample from a developing human oocyte or embryo, acquired via a cycle of in vitro fertilisation (IVF); evaluating the genetic composition of this sample; and using this information to determine which embryos will be optimal for subsequent uterine ...
Paul R, Brezina +2 more
openaire +2 more sources
Epidemiology, 2004
Population-based genetic research has many purposes, one of which is to develop practical applications of prevention and therapy. This obviously includes the possi bility of commercial uses. Although commercialization of genetic testing is not a matter of concern in itself, there is reason to be concerned about premature transfer from research to ...
Paolo, Vineis, David C, Christiani
openaire +2 more sources
Population-based genetic research has many purposes, one of which is to develop practical applications of prevention and therapy. This obviously includes the possi bility of commercial uses. Although commercialization of genetic testing is not a matter of concern in itself, there is reason to be concerned about premature transfer from research to ...
Paolo, Vineis, David C, Christiani
openaire +2 more sources
Medicine, 2016
Genetic testing is now an integral part of most areas of medicine, including neurological disorders. This article provides clinicians with guidance on the issues and pathways for genetic testing, including ethical dilemmas that can arise in the care of families with a confirmed or suspected genetic condition. As genetics moves more into the mainstream,
Henrietta Lefroy +2 more
openaire +1 more source
Genetic testing is now an integral part of most areas of medicine, including neurological disorders. This article provides clinicians with guidance on the issues and pathways for genetic testing, including ethical dilemmas that can arise in the care of families with a confirmed or suspected genetic condition. As genetics moves more into the mainstream,
Henrietta Lefroy +2 more
openaire +1 more source
Veterinary Record, 2008
SIR, — I was interested to read the article on hereditary equine regional dermal asthenia (herda) in a uk horse ([Rendle and others 2008][1]). In the third to last paragraph, it was stated ‘No test has yet been developed to identify carriers of the allele associated with herda.’ We ...
openaire +2 more sources
SIR, — I was interested to read the article on hereditary equine regional dermal asthenia (herda) in a uk horse ([Rendle and others 2008][1]). In the third to last paragraph, it was stated ‘No test has yet been developed to identify carriers of the allele associated with herda.’ We ...
openaire +2 more sources
Chinese Journal of Biotechnology, 2006
Nowadays genetic tests are available in a growing number of countries, for an expanding set of conditions. Nonetheless, many Chinese people are still not familiar with the principle, testing types, technologies used in this process, application and benefits to society, and national or international administration of genetic testing.
Yi, Xie, Mao-Qing, Wu
openaire +2 more sources
Nowadays genetic tests are available in a growing number of countries, for an expanding set of conditions. Nonetheless, many Chinese people are still not familiar with the principle, testing types, technologies used in this process, application and benefits to society, and national or international administration of genetic testing.
Yi, Xie, Mao-Qing, Wu
openaire +2 more sources
Annals of Surgical Oncology, 2014
The commercial introduction of next-generation sequencing has made it possible to test for mutations in all known or suspected breast cancer predisposition genes in one panel, at one time, for about the same cost as a BRCA gene test. Clinicians are increasingly presented with the challenge of advising patients with mutations in rare breast cancer ...
openaire +2 more sources
The commercial introduction of next-generation sequencing has made it possible to test for mutations in all known or suspected breast cancer predisposition genes in one panel, at one time, for about the same cost as a BRCA gene test. Clinicians are increasingly presented with the challenge of advising patients with mutations in rare breast cancer ...
openaire +2 more sources